Deciphera Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United…

Drug Manufacturers - Specialty & Generic
US, Waltham [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Deciphera Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of DCPH's Analysis
CIK: 1654151 CUSIP: 24344T101 ISIN: US24344T1016 LEI: - UEI: -
Secondary Listings
DCPH has no secondary listings inside our databases.